CME Group said it reported total revenues of $1,532.5 million, operating income of $1,000.6 million, net income of $883.2 million and diluted earnings per share of $2.42 for Q2 2024. Total revenues for Q2 2023 were $1,360.2 million.

1. 01

   CME Group said it reported total revenues of $1,532.5 million, operating income of $1,000.6 million, net income of $883.2 million and diluted earnings per share of $2.42 for Q2 2024. Total revenues for Q2 2023 were $1,360.2 million.

2. 02

   CME Group said adjusted net income for Q2 2024 was $932.2 million and diluted adjusted earnings per share were $2.56, compared with $836.4 million and $2.30 for Q2 2023. The adjusted net income calculation includes an add-back of $68.9 million for amortization of purchased intangibles.

3. 03

   The company said average daily volume (ADV) for Q2 2024 was 25.9 million contracts, and non-U.S. ADV reached a record 7.8 million contracts. The average rate per contract was $0.708, and clearing and transaction fees revenue was $1.2 billion.

4. 04

   CME Group said it had approximately $2.0 billion in cash as of June 30, 2024 (including $225 million deposited with the Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. It said dividends paid in Q2 were approximately $419 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.